Business

This week, United Airlines announced the cancellation of 35 roundtrip flights each day from Newark Liberty International Airport due to overwhelming delays that left thousands of travelers stranded. This situation, while alarming, is not unexpected; it lays bare the deeply entrenched system failures that have plagued America’s airline industry for years. CEO Scott Kirby’s acknowledgement
0 Comments
Netflix is currently enjoying an extraordinary unprecedented run, achieving an 11-day streak of stock increases. This impressive performance surpasses even its previous records. While many investors remain skeptical about the sustainability of such riches, one can’t help but acknowledge the underlying indicators that have lifted Netflix to this level—especially during an era marked by economic
0 Comments
General Motors (GM) finds itself navigating the tumultuous waters of the ever-changing trade policy landscape under former President Donald Trump. Recently, the automaker was forced to adjust its 2025 earnings guidance significantly downward, projecting a possible loss of $4 billion to $5 billion due to ongoing auto tariffs. This shocking revelation serves as a wake-up
0 Comments
The automotive industry finds itself at a critical juncture, particularly illustrated by General Motors’ (GM) recent financial performance that both impressively surpassed initial expectations yet raised a specter of uncertainty moving forward. This paradox captures the tumultuous landscape of the automotive market, a fallout of regulatory turbulence, especially surrounding Donald Trump’s auto tariffs and the
0 Comments
In a landmark decision that will undoubtedly reverberate across the pharmaceutical landscape, Novo Nordisk has achieved a significant legal victory against compounding pharmacies attempting to produce cheaper, unapproved versions of its high-demand drugs, Wegovy and Ozempic. This ruling, facilitated by a federal judge in Texas, marks a pivotal moment in the ongoing struggle between pharmaceutical
0 Comments